Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMH1VCE)

Drug Name

2-(2-cyclopentylidenehydrazinyl)-4-phenylthiazole Drug Info

Synonyms

CHEMBL386941; AC1LBKTO; 2-(2-cyclopentylidenehydrazinyl)-4-phenylthiazole; SCHEMBL18998987; WUSIIHCESPBBHG-UHFFFAOYSA-N; MolPort-002-698-743; ZINC7350034; BDBM50326626; STK673148; AKOS005593088; MCULE-7323011972; Cyclopentanone, (4-phenyl-2-thiazolyl)hydrazone; N-(cyclopentylideneamino)-4-phenyl-thiazol-2-amine; 1-cyclopentylidene-2-(4-phenylthiazol-2-yl)hydrazine; N-(cyclopentylideneamino)-4-phenyl-1,3-thiazol-2-amine; A1355/0061138; Cyclopentanone ((2Z)-4-phenyl-1,3-thiazol-2(3H)-ylidene)hydrazone #

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 584447
TTD Drug ID: DMH1VCE

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Monoamine oxidase type A (MAO-A)	TT3WG5C	AOFA_HUMAN	Inhibitor	[1]
Monoamine oxidase type B (MAO-B)	TTGP7BY	AOFB_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
Monoamine oxidase type B (MAO-B)	DTT	MAOB	9.367	6.907	8.237	8.409
Monoamine oxidase type A (MAO-A)	DTT	MAOA	7.207	8.159	9.043	7.711

Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease

Discovery agent

ICD Disease Classification

N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Monoamine oxidase type B (MAO-B)	DTT	MAOB	2.65E-02	1.12E-02	0.07
Monoamine oxidase type A (MAO-A)	DTT	MAOA	8.14E-01	0.05	0.1

Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1	Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors. Bioorg Med Chem. 2010 Jul 15;18(14):5063-70.